(Q34292071)

1 August 2017

1 reference

title

Nonhormonal alternatives for the treatment of hot flashes (English)

1 reference

1 August 2017

Brigitte L Sicat

1

1 reference

1 August 2017

Deborah K Brokaw

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

24

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

79-93

1 reference

Vasomotor flushes in menopausal women

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Initial 17beta-estradiol dose for treating vasomotor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Prescribing hormone replacement therapy for menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Management of hot flashes in breast-cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Core body temperature and circadian rhythm of hot flashes in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Pathophysiology and treatment of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

The role of serotonin in hot flushes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Failure of response of menopausal vasomotor symptoms to clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Venlafaxine for the control of hot flashes: results of a longitudinal continuation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Phase III evaluation of fluoxetine for treatment of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Pilot evaluation of gabapentin for treating hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.79.34812

10.1592/PHCO.24.1.79.34812

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference